TAYSHA GENE THERAPIES INC. - COMMON STOCK

Taysha Gene Therapies Announces Presentations at the Upcoming 29th Annual Meeting of the European Society of Gene & Cell Therapy (ESGCT)  

06 Oct 2022 06:00:00 By Nasdaq GlobeNewswire

Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

11 Aug 2022 06:00:02 By Nasdaq GlobeNewswire

Taysha Gene Therapies to Release Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11

09 Aug 2022 16:22:13 By Nasdaq GlobeNewswire

Taysha Gene Therapies to Participate in Upcoming William Blair Biotech Focus Conference 2022

06 Jul 2022 06:00:00 By Nasdaq GlobeNewswire

Taysha Gene Therapies Announces Annual Stockholder Meeting

13 Jun 2022 07:39:29 By Nasdaq GlobeNewswire

Taysha Gene Therapies to Participate in Upcoming June Investor Conferences and Convention

02 Jun 2022 06:00:00 By Nasdaq GlobeNewswire

Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

16 May 2022 06:00:01 By Nasdaq GlobeNewswire

Taysha Gene Therapies to Release First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 16

11 May 2022 06:00:00 By Nasdaq GlobeNewswire

Taysha Gene Therapies Announces Presentations at the Upcoming 25th Annual Meeting of the American Society of Gene & Cell Therapy

10 May 2022 06:00:02 By Nasdaq GlobeNewswire

Taysha Gene Therapies Receives Orphan Drug Designation from the European Commission for TSHA-120 for the Treatment of Giant Axon Neuropathy (GAN)

03 May 2022 06:00:01 By Nasdaq GlobeNewswire

Taysha Gene Therapies Announces Oral Presentations at the Upcoming 2022 IRSF Rett Syndrome Scientific Symposium and the ASCEND National Summit

25 Apr 2022 06:00:00 By Nasdaq GlobeNewswire

Taysha Gene Therapies to Participate in Upcoming Chardan Genetic Medicines and Cell Therapy Manufacturing Summit

18 Apr 2022 07:00:00 By Nasdaq GlobeNewswire